EARNEST Partners’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-16
Closed -$1.09K 997
2023
Q3
$1.09K Hold
16
﹤0.01% 1059
2023
Q2
$1.31K Hold
16
﹤0.01% 1044
2023
Q1
$1.19K Hold
16
﹤0.01% 1048
2022
Q4
$1.33K Hold
16
﹤0.01% 1045
2022
Q3
$1K Hold
16
﹤0.01% 1088
2022
Q2
$1K Hold
16
﹤0.01% 1107
2022
Q1
$2K Hold
16
﹤0.01% 1048
2021
Q4
$2K Hold
16
﹤0.01% 1053
2021
Q3
$2K Hold
16
﹤0.01% 1054
2021
Q2
$2K Hold
16
﹤0.01% 1058
2021
Q1
$2K Hold
16
﹤0.01% 1062
2020
Q4
$1K Hold
16
﹤0.01% 1144
2020
Q3
$1K Hold
16
﹤0.01% 1108
2020
Q2
$1K Hold
16
﹤0.01% 1093
2020
Q1
$1K Hold
16
﹤0.01% 1047
2019
Q4
$1K Hold
16
﹤0.01% 1128
2019
Q3
$1K Hold
16
﹤0.01% 1117
2019
Q2
$1K Hold
16
﹤0.01% 1132
2019
Q1
$1K Hold
16
﹤0.01% 1136
2018
Q4
$1K Hold
16
﹤0.01% 1124
2018
Q3
$1K Hold
16
﹤0.01% 1140
2018
Q2
$1K Hold
16
﹤0.01% 1147
2018
Q1
$1K Hold
16
﹤0.01% 1131
2017
Q4
$1K Buy
+16
New +$508 ﹤0.01% 1128
2017
Q1
Sell
-16
Closed 822
2016
Q4
$0 Buy
+16
New +$420 ﹤0.01% 1168

Other funds holding TECH

EARNEST Partners's TECH Position: Q4 2023 in Review

EARNEST Partners sold out of Bio-Techne (TECH) in Q4 2023, closing a stake of 16 shares — an estimated $1.09K sold.

EARNEST Partners first reported a position in TECH in Q4 2016 and held it in 25 quarters. The position peaked at $2K in Q1 2022. 531 funds tracked by Wall St. Rank hold TECH as of Q4 2023.

  • EARNEST Partners reported no remaining Bio-Techne position as of Q4 2023 after selling out during the quarter.
  • EARNEST Partners sold 16 Bio-Techne shares in Q4 2023, an estimated $1.09K.
  • EARNEST Partners first reported a position in Bio-Techne in Q4 2016 and held it in 25 quarters.
  • EARNEST Partners's Bio-Techne position peaked at $2K in Q1 2022.
  • 531 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2023.

Based on EARNEST Partners's 13F filing for Q4 2023, filed 14 Feb 2024.